scholarly journals Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer

2018 ◽  
Vol 171 (1) ◽  
pp. 111-120 ◽  
Author(s):  
Aditya Bardia ◽  
Ayca Gucalp ◽  
Noashir DaCosta ◽  
Nashat Gabrail ◽  
Michael Danso ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Androgen Receptor ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Phase 1 ◽  
Phase 1 Study ◽  
Estrogen Receptor Positive ◽  
Receptor Inhibitor

scholarly journals Triple-negative breast cancer that progressed as estrogen receptor-positive skin metastases

2015 ◽  
Vol 30 (3) ◽  
pp. 411 ◽  
Author(s):  
Sang Min Lee ◽  
Eun Jin Kang ◽  
Ju Hee Kim ◽  
Jong Min Yun ◽  
Der Sheng Sun ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Positive Skin ◽  
Skin Metastases ◽  
Estrogen Receptor Positive

scholarly journals Alcohol, smoking, and risk of H er2‐overexpressing and triple‐negative breast cancer relative to estrogen receptor‐positive breast cancer

2018 ◽  
Vol 143 (8) ◽  
pp. 1849-1857 ◽  
Author(s):  
Michelle L. Baglia ◽  
Linda S. Cook ◽  
C. Mei‐Tzu ◽  
Charles Wiggins ◽  
Deirdre Hill ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Estrogen Receptor Positive ◽  
Positive Breast Cancer

scholarly journals Dicer expression in estrogen receptor–positive versus triple-negative breast cancer: an antibody comparison

2016 ◽  
Vol 56 ◽  
pp. 40-51 ◽  
Author(s):  
Nicole S. Spoelstra ◽  
Diana M. Cittelly ◽  
Jessica L. Christenson ◽  
Michael A. Gordon ◽  
Anthony Elias ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Estrogen Receptor Positive ◽  
Dicer Expression
Sign in / Sign up

Export Citation Format

Share Document